CVS Health Corporation (LON: 0HRS)
London
· Delayed Price · Currency is GBP · Price in USD
56.85
-0.08 (-0.14%)
Jan 31, 2025, 7:07 PM BST
CVS Health Revenue
CVS Health had revenue of $94.88B USD in the quarter ending September 30, 2024, with 6.02% growth. This brings the company's revenue in the last twelve months to $367.25B, up 5.96% year-over-year. In the year 2023, CVS Health had annual revenue of $356.62B with 10.88% growth.
Revenue (ttm)
$367.25B
Revenue Growth
+5.96%
P/S Ratio
n/a
Revenue / Employee
$1.22M
Employees
300,000
Market Cap
57.18B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 356.62B | 34.99B | 10.88% |
Dec 31, 2022 | 321.63B | 30.72B | 10.56% |
Dec 31, 2021 | 290.91B | 23.00B | 8.59% |
Dec 31, 2020 | 267.91B | 12.14B | 4.75% |
Dec 31, 2019 | 255.77B | 61.85B | 31.89% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
CVS Health News
- 4 days ago - CVS and Other Healthcare Stocks Are Soaring. Why the Sector Is No Longer Sick. - Barrons
- 4 days ago - Should You Buy CVS Health Stock Before Feb. 12? - The Motley Fool
- 5 days ago - Introducing the CVS Health® app: Your go-to companion for health & wellness - PRNewsWire
- 9 days ago - Walgreens Boots Alliance vs. CVS Health: What's the Better Turnaround Play? - The Motley Fool
- 10 days ago - CVS Health Foundation grants $4 million as part of its new healthy aging initiative - PRNewsWire
- 12 days ago - Rose's Income Garden Portfolio Revealed: Yield 6.2%/Defensive Sector Winners - Seeking Alpha
- 13 days ago - CVS Health Corp (CVS)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus
- 15 days ago - CVS Health: One Ugly Chart, Leverage Issues, Trump Problems, Recession/Competition Risks - Seeking Alpha